Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01250795 · ClinicalTrials.gov registry record · Phase 1
Safety and Immunogenicity Of A Recombinant H5N1 Vaccine In Adults
A Phase 1 study, sponsored by Fraunhofer, Center for Molecular Biotechnology.
- Completed
- Registry status
- Phase 1
- Development phase
- 100
- Enrollment target
NCT01250795 is a Phase 1 study that has completed, run by Fraunhofer, Center for Molecular Biotechnology. The registered enrollment target is 100 participants.
The verdict
NCT01250795, a Phase 1 study, has completed, sponsored by Fraunhofer, Center for Molecular Biotechnology.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety, immunogenicity,and tolerability of a H5N1 Vaccine in healthy adults.
Interventions
- OTHER Saline
- BIOLOGICAL HAI-05 Influenza Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2010-11 |
| Est. Completion | 2011-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01250795
The ClinicalTrials.gov registry entry for NCT01250795 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fraunhofer, Center for Molecular Biotechnology, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT01250795 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01250795 about?
NCT01250795 is a clinical study titled "Safety and Immunogenicity Of A Recombinant H5N1 Vaccine In Adults". The purpose of this study is to assess the safety, immunogenicity,and tolerability of a H5N1 Vaccine in healthy adults.
What is the current status of trial NCT01250795?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 100 participants. The study started on 2010-11. Estimated completion is 2011-07.
What interventions are being tested in trial NCT01250795?
The interventions under investigation include: Saline (OTHER), HAI-05 Influenza Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT01250795?
This trial is sponsored by Fraunhofer, Center for Molecular Biotechnology, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.